Camlin Fine Sciences Ltd
NSE: CAMLINFINE · Specialty Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹153 cr vs borrowings ₹668 cr (FY26): borrowings are higher by ₹515 cr.
- Operating profit covered interest 0.1x in the last 12 months.
- 16.20% of the promoters' shares are pledged (7.8% of all shares).
- Promoter holding fell by 1.05 percentage points in a year, to 48.03% (2026-09-30).
- Operating cash flow was below net profit in 1 of the last 5 years (FY23).
- Net loss in 7 of the last 8 quarters.
- Revenue was higher than a year earlier in 3 of the last 4 quarters.
- Other income was 557% of net profit in the last 12 months.
- Debtor days went from 65 (FY24) to 79 (FY26).
- No dividend in the last 5 financial years.
- Price ₹83.28 on 2026-10-26: -59.3% from the 52-week high, 0.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 423 | 433 | 437 | 424 | 460 | 457 | 425 | 520 |
| EBITDA | -108 | 49 | 54 | 19 | 33 | 5 | 13 | -2 |
| OPM % | -25.5% | 11.3% | 12.3% | 4.5% | 7.3% | 1.0% | 3.1% | -0.4% |
| Other income | 12 | 1 | 10 | 9 | 5 | 3 | 24 | 1 |
| Net profit | -100 | -4 | -1 | -10 | -14 | -36 | 88 | -32 |
| EPS (₹) | -5.98 | -0.24 | -0.04 | -0.53 | -0.76 | -1.91 | 4.59 | -1.65 |
| Revenue YoY | +8.7% | +5.5% | -2.9% | +22.7% | ||||
| Profit YoY | – | – | – | – |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1,412 | 1,682 | 1,613 | 1,667 | 1,723 | 1,862 |
| EBITDA | 153 | 196 | 24 | 198 | 81 | 49 |
| Net profit | 61 | 52 | -93 | -139 | 28 | 6 |
| EPS (₹) | 4.65 | 3.45 | -5.58 | -8.03 | 1.46 | 0.27 |
| Revenue growth | +19.1% | -4.1% | +3.3% | +3.4% | +8.4% | |
| Profit growth | -14.1% | -278.0% | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +0.8% | +7.7% | +8.4% |
| Net profit | -19.1% | -11.5% | – |
| EPS | -24.9% | -18.8% | – |
| Share price | – | -9.4% (2y) | -54.4% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 819 | 865 | 902 | 1,041 |
| Borrowings | – | 780 | 658 | 646 | 668 |
| Cash & equivalents | – | 99 | 94 | 192 | 153 |
| Total assets | – | 2,060 | 1,952 | 2,024 | 2,324 |
| Fixed assets | – | 794 | 757 | 593 | 625 |
| Capital work in progress | – | 41 | 46 | 10 | 33 |
| Investments | – | 8 | 8 | 23 | 30 |
| Receivables | – | 305 | 285 | 328 | 373 |
| Inventory | – | 568 | 513 | 527 | 504 |
| Payables | – | 288 | 325 | 377 | 505 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 145 | 51 | 139 | 27 | 82 |
| Cash from investing | -249 | -125 | -66 | -75 | -53 |
| Cash from financing | 136 | 60 | -86 | 72 | -25 |
| Capex | 214 | 144 | 61 | 42 | 58 |
| Free cash flow | -68 | -93 | 78 | -16 | 24 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 6.4% | -10.7% | -15.4% | 2.7% |
| ROCE % | – | 8.7% | -2.6% | 9.6% | 2.3% |
| Debtor days | – | 66 | 65 | 72 | 79 |
| Inventory days | – | 255 | 205 | 226 | 199 |
| Payable days | – | 129 | 130 | 162 | 200 |
| Cash conversion cycle (days) | – | 192 | 140 | 136 | 78 |
| Working capital days | – | 64 | 60 | 74 | 55 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 48.03% |
| FIIs | 0.95% |
| DIIs | 5.32% |
| of which Mutual funds | 4.97% |
| Public (non-institutions) | 45.70% |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Nov 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 49.10% | 49.10% | 49.08% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% |
| Promoter group | % |
|---|---|
| Ashish Subhash Dandekar | 10.30% |
| Infinity Direct Holdings | 10.18% |
| Anfima Nv | 8.83% |
| Infinity Holdings | 6.20% |
| Infinity Direct Capital | 4.82% |
| Camart Finance Limited | 2.77% |
| Anagha Subhash Dandekar | 1.57% |
| Vibha Agencies Pvt Ltd | 1.36% |
| Infinity Portfolio Holdings | 1.17% |
| Cafco Consultants Limited | 0.78% |
| Radha Pandit | 0.04% |
| Anand Y Pandit | 0.01% |
| MK Falcon Agro tech Pvt. Ltd. | 0.00% |
| Public holders above 1% | % |
|---|---|
| Icici Prudential Commodities Fund | 4.97% |
| Nirmal Vinod Momaya | 1.88% |
| Ajay Upadhyaya | 1.38% |
| Jagdish N Master | 1.02% |
56,981 shareholders. Pledged: 16.20% of promoter shares.
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| CAMLINFINE | ₹1,600 cr | 308.4x | 1.5x | 0.6% | 0.4% | 2.6% | +0.8% | – |
Business segments (2026-06-30)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Specialty Ingredients | ₹401 cr | 61.4% | ₹26 cr | 6.3% |
| Performance Chemicals & Others | ₹175 cr | 26.8% | ₹-4 cr | -2.5% |
| Aroma | ₹77 cr | 11.8% | ₹-3 cr | -4.4% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2025-01-08 | Rights | Rights 5:41 @ Premium Rs 109/- |
| 2024-07-24 | Other | Annual General Meeting |
| 2023-07-24 | Other | Annual General Meeting |
| 2022-07-21 | Other | Annual General Meeting |
| 2021-07-12 | Other | Annual General Meeting |
| 2020-07-31 | Other | Annual General Meeting |
| 2019-07-25 | Other | Annual General Meeting |
| 2018-08-03 | Other | Annual General Meeting |
| 2017-07-13 | Other | Annual General Meeting |
| 2016-07-28 | Dividend | Annual General Meeting/ Dividend - Re 0.45/- Per Share |
| 2015-07-27 | Dividend | Annual General Meeting/Dividend - Re 0.45/- Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Manufacturing and related activities: Business of manufacture of diverse high-quality innovative specialty ingredients, aroma ingredients, performance chemical products, Health & Wellness products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | CAMLINFINE |
| BSE code | 532834 |
| ISIN | INE052I01032 |
| Face value | ₹1.0 |
| Incorporated | 1993-11-30 |
| Website | www.camlinfs.com |
| Plants (India / abroad) | 2 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.